Clinical trial
S9804: Vinorelbine in Treating Patients With Stage IV Melanoma
NCT00003828 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00003828 |
|---|---|
| Title | S9804: Vinorelbine in Treating Patients With Stage IV Melanoma |
| Official title | Evaluation of Vinorelbine Tartrate (Navelbine) in Patients With Disseminated Malignant Melanoma and One Prior Systemic Therapy |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Drug |
| Interventions | vinorelbine |
| Enrollment | 24 |
| Start date | May 1, 1999 |
| Primary completion | Dec 1, 2001 |
| Completion | Mar 1, 2004 |
| First posted | Aug 4, 2004 |
| Last update posted | Aug 22, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: